MedPath

To evaluate the functional outcomes inshoulder impingement syndrometreated with arthroscopic subacromialdecompression and platelet richplasma (PRP) augmentatio

Phase 3
Conditions
Health Condition 1: M249- Joint derangement, unspecified
Registration Number
CTRI/2024/04/066159
Lead Sponsor
Pt BD Sharma PGIMS Rohtak
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

The inclusion criteria will be skeletally mature patients with shoulder pain lasting for

atleast 3 months with clinical diagnosis of shoulder impingement syndrome confirmed

with MRI scan.

Exclusion Criteria

1. Radicular pain.

2. Presence of pathologies such as frozen shoulder, calcific tendinitis, biceps

subluxation, and a superior labrum anterior posterior lesion.

3. Previous shoulder surgery within last 6 months.

4. Connective tissue disorders such as rheumatoid arthritis, polymyalgia

rheumatica, or fibromyalgia.

5. Full thickness rotator cuff tear on MRI.

6. Ligamentous laxity (positive sulcus test) or shoulder dislocation (positive

apprehension test).

7. Prior corticosteroid injection within 3 months of the study.

8. Haemotological and bleeding diathesis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome <br/ ><br>will be assessed during follow up period as per VAS Score, Constant Score, UCLA Score.Timepoint: Outcome <br/ ><br>will be assessed during follow up period as per VAS Score, Constant Score, UCLA Score at 3 week, 3 months and 6 months
Secondary Outcome Measures
NameTimeMethod
Any kind of skin reaction, pain and <br/ ><br>complication will be noted during follow up period.Timepoint: Any kind of skin reaction, pain and <br/ ><br>complication will be noted during follow up period of 3 week, 3 months and 6 months
© Copyright 2025. All Rights Reserved by MedPath